Literature DB >> 29550758

Thrombotic microangiopathy associated with Mycoplasma pneumoniae infection.

Filipa Caeiro Alves1, Rute Aguiar1, Pedro Pessegueiro1, Carlos Pires1.   

Abstract

Thrombotic microangiopathy (TMA) comprises a process of sequential endothelial damage, microvascular thrombosis, consumptive thrombocytopenia and microangiopathic haemolytic anaemia that can affect several organs, including the kidney. A 36-year-old woman was presented with a petechial rash 3 weeks after an upper respiratory tract infection. Laboratory results showed normocytic normochromic anaemia, thrombocytopenia and evidence of TMA with decreased haptoglobin, elevated serum lactate dehydrogenase and a peripheral blood smear with numerous schistocytes. Treatment included daily plasmapheresis and prednisolone, with favourable clinical evolution. Antibodies anti-ADAMTS13 were positive, establishing the diagnosis of acquired thrombotic thrombocytopenic purpura. There was also serological evidence of a recent infection by Mycoplasma pneumoniae, and therefore the preceding respiratory tract infection by this agent was the most likely trigger for the disease. Due to the high mortality rate and poor outcomes, the prompt diagnostic and treatment are crucial in this rare disease. The identification of triggers related to this pathology can allow new therapeutic targets or preventive strategies. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); immunology; renal medicine

Mesh:

Substances:

Year:  2018        PMID: 29550758      PMCID: PMC5878407          DOI: 10.1136/bcr-2017-222582

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  32 in total

Review 1.  Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura.

Authors:  E Bar Meir; H Amital; Y Levy; A Kneller; Y Bar-Dayan; Y Shoenfeld
Journal:  Acta Haematol       Date:  2000       Impact factor: 2.195

2.  Thrombotic microangiopathy after kidney transplantation.

Authors:  M Noris; G Remuzzi
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 3.  ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.

Authors:  Claudia Tersteeg; Sebastien Verhenne; Elien Roose; An-Sofie Schelpe; Hans Deckmyn; Simon F De Meyer; Karen Vanhoorelbeke
Journal:  Expert Rev Hematol       Date:  2015-12-08       Impact factor: 2.929

4.  Thrombotic thrombocytopenic purpura due to Mycoplasma pneumoniae.

Authors:  D Cameron; P Welsby; M Turner
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

Review 5.  Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.

Authors:  Boris Shenkman; Yulia Einav
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

6.  How I treat patients with thrombotic thrombocytopenic purpura: 2010.

Authors:  James N George
Journal:  Blood       Date:  2010-08-04       Impact factor: 22.113

7.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors:  M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

8.  ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.

Authors:  Flora Peyvandi; Silvia Lavoretano; Roberta Palla; Hendrik B Feys; Karen Vanhoorelbeke; Tullia Battaglioli; Carla Valsecchi; Maria Teresa Canciani; Fabrizio Fabris; Samo Zver; Marienn Réti; Danijela Mikovic; Mehran Karimi; Gaetano Giuffrida; Luca Laurenti; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2008-01-26       Impact factor: 9.941

Review 9.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

Review 10.  Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.

Authors:  Bodo B Beck; FrancJan van Spronsen; Arjan Diepstra; Rolf M F Berger; Martin Kömhoff
Journal:  Pediatr Nephrol       Date:  2016-06-11       Impact factor: 3.714

View more
  3 in total

Review 1.  Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.

Authors:  Aicha Laghmouchi; Nuno A G Graça; Jan Voorberg
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 2.  Complement in Secondary Thrombotic Microangiopathy.

Authors:  Lilian Monteiro Pereira Palma; Meera Sridharan; Sanjeev Sethi
Journal:  Kidney Int Rep       Date:  2020-10-21

Review 3.  Thrombosis associated with mycoplasma pneumoniae infection (Review).

Authors:  Jingwei Liu; Yumei Li
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.